Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram dosing in elderly depression
2005-003821-25Phase 4Terminated
- Sponsor
- Psychiatric Hospital
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive episode (MDE), recurrent depressive disorder (RDD) and Organic depressive disorder comparing Escitalopram with Placebo (2 arms). Primary endpoint: Remission by HAM-D6. Started Aug 2005; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive episode (MDE)recurrent depressive disorder (RDD)Organic depressive disorder
Beyond the preview
Go deeper on 2005-003821-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003821-25.